Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Mar 28, 2010; 16(12): 1506-1511
Published online Mar 28, 2010. doi: 10.3748/wjg.v16.i12.1506
Figure 1
Figure 1 Administration of peg-interferon (PEG-IFN) α2a. The patients received subcutaneous injections of 180 μg of PEG-IFN α2a (rotundity) once per week. Twenty-one patients (Pts. 1-21) completed a 12-wk treatment course without dose reduction. In 17 patients (Pts. 22-38), the dose was reduced to 90 μg (triangle) or the treatment was terminated before completion of the 12-wk course.